Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

MGF Igf-1-ec

IGF-1Ec, IGF-1Eb, Mechano-Growth Factor

Quick Stats
Studies 62
Trials 100
Enrolling By Invitation NA INTERVENTIONAL NCT06629805

β-glucan and Exercise on Musculoskeletal Function in Sarcopenic Adults

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

The investigators will conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Aureobasidium pullulans produced β-glucan and regular combined exercise on muscle strength, muscle mass, muscle function, and biomarkers in adults with relative sarcopenia for 12 weeks.

Detailed Description

A previous human study has indicated that Aureobasidium pullulans produced β-glucan may increase muscle mass and strength in the elderly. Therefore, the investigators will conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Aureobasidium pullulans produced β-glucan on muscle strength, muscle mass, and muscle function, expanding the target population to adults aged 50 and older with relative sarcopenia, the safety of the compound are also evaluated. The Investigators examine the peak torque/body weight at 60°/s knee extension, handgrip strength, skeletal muscle mass, physical performance, and metabolic parameters at baseline and 12 weeks of intervention. Eighty adults were administered either 1,000 mg of Aureobasidium pullulans produced β-glucan or a placebo each day for 12 weeks.

Interventions

Name: Aureobasidium pullulans produced β-glucan
Type: DIETARY_SUPPLEMENT
Description: Aureobasidium pullulans produced β-glucan 1,000 mg/day for 12 weeks
Name: Placebo
Type: DIETARY_SUPPLEMENT
Description: Placebo 1,000 mg/day for 12 weeks

Primary Outcomes

Measure: Muscle strength
TimeFrame: 12 weeks
Description: The peak torque at 60°/s knee extension (/kg), right, left and the peak torque at 60°/s knee flexion (/kg), right, left
Measure: TUG test
TimeFrame: 12 weeks
Description: Timed Up \& Go test

Trial Information

NCT ID

NCT06629805

Status

Enrolling By Invitation

Study Type

INTERVENTIONAL

Phases

NA

Sponsor

Pusan National University Yangsan Hospital

Last Updated

December 15, 2025